Field Application and Business Development - Revvity - Northern California
Managed scientific and commercial activities across an approximately $3.5M Northern California territory serving biotechnology, pharmaceutical, academic, diagnostic, and healthcare organizations.
- Contributed approximately $1.2M in new business while supporting an active commercial opportunity pipeline exceeding $2M.
- Identified and developed new opportunities through outbound customer engagement, scientific consultation, account mapping, workflow assessment, and relationship development.
- Built relationships across major Bay Area organizations including Genentech, Gilead, UCSF, Stanford, Arc Institute, Chan Zuckerberg Biohub, Buck Institute, and emerging biotechnology companies.
- Engaged scientific and commercial stakeholders around genomics, transcriptomics, spatial biology, biomarker discovery, multi-omics, and translational research applications.
- Translated complex technology capabilities into customer-specific scientific and commercial value propositions.
- Developed multi-threaded relationships across accounts to identify new buying centers, applications, and opportunities.
- Partnered with Business Development, Sales, Product Management, Marketing, Applications, and technical teams to advance complex opportunities.
- Supported opportunity qualification, proposal development, customer evaluations, commercial strategy, and deal progression.
- Prepared and delivered scientific presentations, workshops, seminars, strategic account reviews, and executive-level customer briefings.
- Maintained disciplined CRM records, opportunity pipelines, forecasts, competitive information, and customer follow-up.
- Represented the organization at scientific meetings, conferences, and customer events.
Founding Member | Lead Scientific & Business Strategy Consultant - OncoMDx
Served as a founding member, contributing to company strategy, business development, scientific development, and commercialization of molecular oncology and precision-diagnostic capabilities.
- Identified and evaluated business-development and partnership opportunities supporting company growth.
- Participated in end-to-end deal activities, including opportunity assessment, partner discussions, scientific and commercial diligence, deal structuring, term development, negotiation, and execution.
- Worked with leadership and external stakeholders to evaluate scientific fit, strategic value, market opportunity, implementation requirements, and partnership economics.
- Supported development of proposals, business cases, partnership structures, and commercial recommendations.
- Conducted market and competitive assessments to prioritize opportunities within molecular oncology and diagnostics.
- Helped translate scientific capabilities into differentiated customer and partner value propositions.
- Coordinated scientific, technical, operational, vendor, commercial, and leadership stakeholders through implementation.
- Contributed to development and commercialization of molecular diagnostic assays and precision-oncology services.
Scientific & Business Strategy Consultant - Diacarta Inc.
Worked directly with the Chief Scientific Officer on molecular diagnostic product-development and commercialization initiatives.
- Conducted strategic market assessments across the United States, India, and UAE to identify opportunities based on unmet need, competitive dynamics, scientific feasibility, market potential, and ROI.
- Helped prioritize product-development opportunities across oncology, HPV, infectious diseases, and biomarker diagnostics.
- Synthesized scientific, market, competitive, and commercial information into recommendations for leadership.
- Developed and optimized qPCR-based diagnostic assays using multiple chemistries.
- Contributed to CRISPR-related technology initiatives.
- Helped connect scientific innovation with market opportunity and commercialization strategy.
Scientific & Strategy Consultant — AI / Immuno-Oncology - iNDX.AI
- Helped develop an AI-enabled immuno-oncology analysis pipeline using transcriptomic data.
- Worked at the interface of computational biology, oncology, biomarkers, and potential pharmaceutical applications.
- Translated computational outputs into biologically meaningful insights relevant to biomarker discovery and precision medicine.
- Contributed to strategic discussions around potential biotech/pharma use cases for AI-enabled analytical capabilities.
- Helped translate technical platform capabilities into scientifically and commercially relevant value propositions.
- Collaborated across scientific and computational disciplines to connect platform capabilities with customer needs.
Researcher / Laboratory Manager - University of California, San Francisco - San Francisco
Managed translational oncology research while managing multidisciplinary scientific programs and research operations.
- Managed personnel, budgets, procurement, infrastructure, regulatory requirements, collaborations, scientific resources, and multiple concurrent programs.
- Developed project plans, scientific strategies, milestones, and execution priorities.
- Coordinated investigators, scientists, trainees, administrators, institutional functions, vendors, and external collaborators.
- Synthesized complex scientific information into presentations, publications, funding materials, and recommendations.
- Led development and transformation of research capabilities as scientific and organizational priorities evolved.
- Managed implementation of new technologies and research platforms from strategic need through operational adoption.
- Mentored scientists, technicians, graduate students, and postdoctoral researchers.
Postdoctoral Fellow - Hospital for Sick Children, University of Toronto - Toronto
Conducted translational oncology research focused on the tumor microenvironment.
- Integrated molecular, cellular, and analytical approaches to investigate tumor biology.
- Contributed to development of advanced research capabilities supporting translational cancer studies.
